Hemostasis Reference LaboratoryFactor VII Activity
A one-stage extrinsic system clotting assay is used to measure circulating factor VII level. Clotting times of dilutions of patient plasma are compared to dilutions of a plasma pool from normal donors, when added to deficient plasma. Levels are reduced by hereditary or acquired factor VII deficiency, vitamin K deficiency, liver disease, warfarin therapy, or disseminated intravascular coagulation (DIC). A common polymorphism can account for mildly reduced levels when heterozygous; homozygotes average 30-40% with normal hemostasis. In epidemiologic studies, low - normal factor VII levels are correlated with reduced risk of coronary artery thrombosis but this is of little predictive value for individual patients.
|
Questions: 206-292-6594
|